참고문헌 (51)

1. Al-Goblan A. S. Al-Alfi M. A. Khan M. Z. ( 2014 ). Mechanism linking diabetes mellitus and obesity. Diabetes Metab. Syndr. Obes. 7 587 – 591 . 10.2147/DMSO.S67400 25506234 

   상세보기

2. Axelsson A. S. Mahdi T. Nenonen H. A. Singh T. Hänzelmann S. Wendt A. ( 2017 ). Sox5 regulates beta-cell phenotype and is reduced in type 2 diabetes. Nat. Commun. 8 : 15652 . 10.1038/ncomms15652 28585545 

   상세보기

3. Bahadoran Z. Mirmiran P. Azizi F. ( 2013 ). Dietary polyphenols as potential nutraceuticals in management of diabetes: a review. J. Diabetes Metab. Disord. 12 : 43 . 10.1186/2251-6581-12-43 23938049 

   상세보기

4. Båvenholm P. N. Pigon J. Östenson C. G. Efendic S. ( 2001 ). Insulin sensitivity of suppression of endogenous glucose production is the single most important determinant of glucose tolerance. Diabetes Metab. Res. Rev. 50 1449 – 1454 . 10.2337/diabetes.50.6.1449 11375347 

   상세보기

5. Butkowski E. G. Jelinek H. F. ( 2017 ). Hyperglycaemia, oxidative stress and inflammatory markers. Redox Rep. 22 257 – 264 . 10.1080/13510002.2016.1215643 28277069 

   상세보기

6. Cao H. Hininger-Favier I. Kelly M. A. Benaraba R. Dawson H. D. Coves S. ( 2007 ). Green tea polyphenol extract regulates the expression of genes involved in glucose uptake and insulin signaling in rats fed a high fructose diet. J. Agric. Food Chem. 55 6372 – 6378 . 10.1021/jf070695o 17616136 

   상세보기

7. Cecchini M. Sassi F. Lauer J. A. Lee Y. Y. Guajardo-Barron V. Chisholm D. ( 2010 ). Tackling of unhealthy diets, physical inactivity, and obesity: health effects and cost-effectiveness. Lancet 376 1775 – 1784 . 10.1016/S0140-6736(10)61514-0 21074255 

   상세보기

8. Cersosimo E. Triplitt C. Mandarino L. J. DeFronzo R. A. ( 2015 ). Pathogenesis of type 2 diabetes mellitus. Arch. Med. Res. 36 197 – 209 . 

9. Cherrington A. D. ( 1999 ). Control of glucose uptake and release by the liver in vivo. Diabetes Metab. Res. Rev. 48 1198 – 1214 . 

10. Clark-Knowles K. V. Dewar-Darch D. Jardine K. E. McBurney M. W. ( 2014 ). Modulation of tumorigenesis by dietary intervention is not mediated by SIRT1 catalytic activity. PLoS One 9 : e112406 . 10.1371/journal.pone.0112406 25380034 

    상세보기

11. Cusi K. Consoli A. Defronzo R. A. ( 1996 ). Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 81 4059 – 4067 . 8923861 

    상세보기

12. Dubey R. K. Gillespie D. G. Imthurn B. Rosselli M. Jackson E. K. Keller P. J. ( 1999 ). Phytoestrogens inhibit growth and MAP kinase activity in human aortic smooth muscle cells. Hypertension 33 177 – 182 . 10.1161/01.HYP.33.1.177 9931101 

    상세보기

13. Gheibi S. Kashfi K. Ghasemi A. ( 2017 ). A practical guide for induction of type-2 diabetes in rat: incorporating a high-fat diet and streptozotocin. Biomed. Pharmacother. 95 605 – 613 . 10.1016/j.biopha.2017.08.098 28881291 

    상세보기

14. Holman R. R. Paul S. K. Bethel M. A. Matthews D. R. Neil H. A. W. ( 2008 ). 10-year follow-up of intensive glucose control in type 2 diabetes. N. Engl. J. Med. 359 1577 – 1589 . 10.1056/NEJMoa0806470 18784090 

    상세보기

15. International Diabetes Federation [IDF] ( 2015 ). Framework for Action on Sugar. Brussels : International Diabetes Federation . 

16. International Diabetes Federation [IDF] ( 2017 ). Diabetes Atlas 8th Edn. Brussels : International Diabetes Federation . 

17. Kaczmarczyk-Sedlak I. Wojnar W. Zych M. Ozimina-Kamińska E. Taranowicz J. Siwek A. ( 2013 ). Effect of formononetin on mechanical properties and chemical composition of bones in rats with ovariectomy-induced osteoporosis. Evid. Based Complement. Alternat. Med. 2013 : 457052 . 10.1155/2013/457052 23762138 

    상세보기

18. Kitada M. Koya D. ( 2013 ). SIRT1 in type 2 diabetes: mechanisms and therapeutic potential. Diabetes Metab. J. 37 315 – 325 . 10.4093/dmj.2013.37.5.315 24199159 

    상세보기

19. Koenig R. J. Peterson C. M. Jones R. L. Saudek C. Lehrman M. Cerami A. ( 1976 ). Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus. N. Engl. J. Med. 295 417 – 420 . 10.1056/NEJM197608192950804 934240 

    상세보기

20. Krauss R. M. ( 2004 ). Lipids and lipoproteins in patients with type 2 diabetes. Diabetes Care 27 1496 – 1504 . 10.2337/diacare.27.6.1496 15161808 

    상세보기

21. Kulkarni R. N. Brüning J. C. Winnay J. N. Postic C. Magnuson M. A. Kahn C. R. ( 1999 ). Tissue-specific knockout of the insulin receptor in pancreatic β cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96 329 – 339 . 10.1016/S0092-8674(00)80546-2 10025399 

    상세보기

22. Kulkarni Y. A. Garud M. S. ( 2016 ). Bauhinia variegata (Caesalpiniaceae) leaf extract: an effective treatment option in type I and type II diabetes. Biomed. Pharmacother. 83 122 – 129 . 10.1016/j.biopha.2016.06.025 27470559 

    상세보기

23. Kulkarni Y. A. Garud M. S. Oza M. J. Barve K. H. Gaikwad A. B. ( 2016 ). “Diabetes, diabetic complications, and flavonoids,” in Fruits, Vegetables, and Herbs eds Watson R. R. Preedy V. R. ( New York City, NY : Elsevier Science ) 77 – 104 . 10.1016/B978-0-12-802972-5.00005-6 

    

24. Ley S. H. Hamdy O. Mohan V. Hu F. B. ( 2014 ). Prevention and management of type 2 diabetes: dietary components and nutritional strategies. Lancet 383 1999 – 2007 . 10.1016/S0140-6736(14)60613-9 24910231 

    상세보기

25. Lu M. P. Wang R. Song X. Chibbar R. Wang X. Wu L. ( 2008 ). Dietary soy isoflavones increase insulin secretion and prevent the development of diabetic cataracts in streptozotocin-induced diabetic rats. Nutr. Res. 28 464 – 471 . 10.1016/j.nutres.2008.03.009 19083447 

    상세보기

26. Ma W. Nomura M. Takahashi-Nishioka T. Kobayashi S. ( 2007 ). Combined effects of fangchinoline from Stephania tetrandra radix and formononetin and calycosin from Astragalus membranaceus radix on hyperglycemia and hypoinsulinemia in streptozotocin-diabetic mice. Biol. Pharm. Bull. 30 2079 – 2083 . 10.1248/bpb.30.2079 17978479 

    상세보기

27. Mari A. Wahren J. DeFronzo R. A. Ferrannini E. ( 1994 ). Glucose absorption and production following oral glucose: comparison of compartmental and arteriovenous-difference methods. Metabolism 43 1419 – 1425 . 10.1016/0026-0495(94)90038-8 7968597 

    상세보기

28. Mozaffarian D. Afshin A. Benowitz N. L. Bittner V. Daniels S. R. Franch H. A. ( 2012 ). Population approaches to improve diet, physical activity, and smoking habits. Circulation 126 1514 – 1563 . 10.1161/CIR.0b013e318260a20b 22907934 

    상세보기

29. Mu H. Bai Y. H. Wang S. T. Zhu Z. M. Zhang Y. W. ( 2009 ). Research on antioxidant effects and estrogenic effect of formononetin from Trifolium pratense (red clover). Phytomedicine 16 314 – 319 . 10.1016/j.phymed.2008.07.005 18757188 

    상세보기

30. Nestel P. J. Pomeroy S. Kay S. Komesaroff P. Behrsing J. Cameron J. D. ( 1999 ). Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women. J. Clin. Endocrinol. Metab. 84 895 – 898 . 10.1210/jc.84.3.895 10084567 

    

31. Nestel P. Fujii A. Zhang L. ( 2007 ). An isoflavone metabolite reduces arterial stiffness and blood pressure in overweight men and postmenopausal women. Atherosclerosis 192 184 – 189 . 10.1016/j.atherosclerosis.2006.04.033 16730732 

    상세보기

32. Ohtsubo K. Chen M. Z. Olefsky J. M. Marth J. D. ( 2011 ). Pathway to diabetes through attenuation of pancreatic beta cell glycosylation and glucose transport. Nat. Med. 17 1067 – 1075 . 10.1038/nm.2414 21841783 

    상세보기

33. Oza M. J. Kulkarni Y. A. ( 2016 ). Phytochemicals and complications in type 2 diabetes-An update. Int. J. Pharm. Sci. Res. 7 : 14 . 

34. Pulla V. K. Alvala M. Sriram D. S. Viswanadha S. Sriram D. Yogeeswari P. ( 2014 ). Structure-based drug design of small molecule SIRT1 modulators to treat cancer and metabolic disorders. J. Mol. Graph. Model. 52 46 – 56 . 10.1016/j.jmgm.2014.06.005 25000096 

    상세보기

35. Qiu G. Tian W. Huan M. Chen J. Fu H. ( 2017 ). Formononetin exhibits anti-hyperglycemic activity in alloxan-induced type 1 diabetic mice. Exp. Biol. Med. 242 223 – 230 . 10.1177/1535370216657445 27412955 

    상세보기

36. Qiu L. Ye H. Chen L. Hong Y. Zhong F. Zhang T. ( 2012 ). Red clover extract ameliorates dyslipidemia in streptozotocin-induced diabetic C57BL/6 mice by activating hepatic PPARα. Phytother. Res. 26 860 – 864 . 10.1002/ptr.3641 22084061 

    상세보기

37. Rasbach K. A. Schnellmann R. G. ( 2008 ). Isoflavones promote mitochondrial biogenesis. J. Pharmacol. Exp. Ther. 325 536 – 543 . 10.1124/jpet.107.134882 18267976 

    상세보기

38. Rüfer C. E. Kulling S. E. ( 2006 ). Antioxidant activity of isoflavones and their major metabolites using different in vitro assays. J. Agric. Food Chem. 54 2926 – 2931 . 10.1021/jf053112o 16608210 

    상세보기

39. Seifter S. Dayton S. Novic B. Muntwyler E. ( 1950 ). The estimation of glycogen with the anthrone reagent. Arch. Biochem. 25 191 – 200 . 15401229 

40. Shanik M. H. Xu Y. Škrha J. Dankner R. Zick Y. Roth J. ( 2008 ). Insulin resistance and hyperinsulinemia. Diabetes Care 31(Suppl. 2) S262 – S268 . 10.2337/dc08-s264 18227495 

    상세보기

41. Sharma R. D. ( 1979 ). Isoflavones and hypercholesterolemia in rats. Lipids 14 535 – 540 . 10.1007/BF02533528 459719 

    상세보기

42. Shen P. Liu M. H. Ng T. Y. Chan Y. H. Yong E. L. ( 2006 ). Differential effects of isoflavones, from Astragalus membranaceus and Pueraria thomsonii , on the activation of PPARα, PPARγ, and adipocyte differentiation in vitro. J. Nutr. 136 899 – 905 . 10.1093/jn/136.4.899 16549448 

    상세보기

43. Sherwani S. I. Khan H. A. Ekhzaimy A. Masood A. Sakharkar M. K. ( 2016 ). Significance of hba1c test in diagnosis and prognosis of diabetic patients. Biomark. Insights 11 95 – 104 . 10.4137/BMI.S38440 27398023 

    상세보기

44. Shoba B. Lwin Z. M. Ling L. S. Bay B. H. Yip G. W. Kumar S. D. ( 2009 ). Function of sirtuins in biological tissues. Anat. Rec. 292 536 – 543 . 10.1002/ar.20875 19301279 

    상세보기

45. Srinivasan K. Viswanad B. Asrat L. Kaul C. L. Ramarao P. ( 2005 ). Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol. Res. 52 313 – 320 . 10.1016/j.phrs.2005.05.004 15979893 

    상세보기

46. Tsuneki H. Ishizuka M. Terasawa M. Wu J. B. Sasaoka T. Kimura I. ( 2004 ). Effect of green tea on blood glucose levels and serum proteomic patterns in diabetic (db/db) mice and on glucose metabolism in healthy humans. BMC Pharmacol. 4 18 – 22 . 10.1186/1471-2210-4-18 15331020 

    상세보기

47. Vassilopoulos A. Fritz K. S. Petersen D. R. Gius D. ( 2011 ). The human sirtuin family: evolutionary divergences and functions. Hum. Genomics. 5 485 – 496 . 21807603 

48. Wang Y. Zhu Y. Gao L. Yin H. Xie Z. Wang D. ( 2012 ). Formononetin attenuates IL-1β-induced apoptosis and NF-κB activation in INS-1 cells. Molecules 17 10052 – 10064 . 10.3390/molecules170910052 22922276 

    상세보기

49. World Health Organization and UN Food, and Agriculture Organization ( 2002 ). Diet, nutrition and the prevention of chronic diseases: report of a joint WHO/FAO expert consultation. Geneva : WHO . 

50. Yacoub R. Lee K. He J. C. ( 2014 ). The role of SIRT1 in diabetic kidney disease. Front. Endocrinol. 5 : 166 10.3389/fendo.2014.00166 

    상세보기

51. Zhang F. Ye C. Li G. Ding W. Zhou W. Zhu H. ( 2003 ). The rat model of type 2 diabetic mellitus and its glycometabolism characters. Exp. Anim. 52 401 – 407 . 10.1538/expanim.52.401 14625406 

    상세보기